| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/12/2004 | EP1416974A1 Gas microsphere liposome composites |
| 05/12/2004 | EP1416970A2 Conjugate |
| 05/12/2004 | EP1416966A2 Methods for treating joint inflammation, pain, and loss of mobility |
| 05/12/2004 | EP1416964A2 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 05/12/2004 | EP1416961A1 Composition and method for the treatment of disease |
| 05/12/2004 | EP1416950A1 Artichoke leaf extracts |
| 05/12/2004 | EP1416949A1 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba |
| 05/12/2004 | EP1416948A1 Compositions for removal of toxins |
| 05/12/2004 | EP1416942A1 Method for treating gout and binding uric acid |
| 05/12/2004 | EP1416941A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 05/12/2004 | EP1416940A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 05/12/2004 | EP1416939A2 Method of treating malignancy associated hypercalcemia using active vitamin d analogues |
| 05/12/2004 | EP1416938A1 Delayed and sustained drug release |
| 05/12/2004 | EP1416937A1 Prophylactic and therapeutic use of hydroxysteroids |
| 05/12/2004 | EP1416936A1 Thiopyrane-4-ones as dna protein kinase inhibitors |
| 05/12/2004 | EP1416935A1 4-amino-6-phenyl-pyrrolo 2,3-d]pyrimidine derivatives |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1416932A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels |
| 05/12/2004 | EP1416931A1 Inhibitors of polyq-aggregation |
| 05/12/2004 | EP1416930A1 Pramipexole for the treatment of adhd |
| 05/12/2004 | EP1416929A2 Cancer treatment with gö6976 and its related compounds |
| 05/12/2004 | EP1416928A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 05/12/2004 | EP1416927A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect |
| 05/12/2004 | EP1416926A2 Zinc containing compositions for anti-viral use |
| 05/12/2004 | EP1416925A2 Uses of targeted oxidative therapeutic formulation in arteriosclerosis |
| 05/12/2004 | EP1416924A1 Adjuvant chemotherapy for anaplastic gliomas |
| 05/12/2004 | EP1416923A1 Reduction of hair growth |
| 05/12/2004 | EP1416922A1 Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 05/12/2004 | EP1416921A2 Once-a-day oxycodone formulations |
| 05/12/2004 | EP1416920A2 Multiplex drug delivery system suitable for oral administration |
| 05/12/2004 | EP1416919A1 Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate |
| 05/12/2004 | EP1416916A1 Chitin microparticles and their medical uses |
| 05/12/2004 | EP1416915A1 Enhanced pharmacokinetic profile of hydrophobic substances |
| 05/12/2004 | EP1416914A1 Expandable gastric retention device |
| 05/12/2004 | EP1416907A1 Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 05/12/2004 | EP1416885A2 Methods and devices for delivery of therapeutic capable agents with variable release profile |
| 05/12/2004 | EP1416884A2 Delivery of therapeutic capable agents |
| 05/12/2004 | EP1416842A2 Pharmaceutical combinations of oxycodone and naloxone |
| 05/12/2004 | EP1416812A1 Lipid blends and food products containing oleic fatty acid and omega-6 fatty acids, designed to increase the intramyocellular lipid level |
| 05/12/2004 | EP1416809A1 Animal feed with low pufa concentration |
| 05/12/2004 | EP1416799A1 Methods and compositions for treating fungal infections |
| 05/12/2004 | EP1416795A1 Compositions and methods for treatment of mitochondrial diseases |
| 05/12/2004 | EP1383464A4 Nail compositions and methods of administering same |
| 05/12/2004 | EP1372674A4 Facially amphiphilic polymers as anti-infective agents |
| 05/12/2004 | EP1372551A4 Facially amphiphilic polymers as anti-infective agents |
| 05/12/2004 | EP1367046A9 Disubstituted lavendustin A analogs and pharmaceutical compositions comprising the analogs |
| 05/12/2004 | EP1345936B1 Method for producing the anticholinergic agent tiotropium bromide |
| 05/12/2004 | EP1335732B1 Food item for increasing cognitive capacity |
| 05/12/2004 | EP1311485A4 Processes for preparing cilostazol |
| 05/12/2004 | EP1309352B1 Antifungal ketoconazole composition for topical use |
| 05/12/2004 | EP1292303B1 A stable pharmaceutical formulation comprising torsemide modification ii |
| 05/12/2004 | EP1265903B1 Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 05/12/2004 | EP1257274B1 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid for treating infectious diseases |
| 05/12/2004 | EP1237856B1 New tri-substituted phenyl derivatives and analogues |
| 05/12/2004 | EP1218352B1 Benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity |
| 05/12/2004 | EP1208095B1 Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes |
| 05/12/2004 | EP1200432B1 Amido spiropiperidines promote the release of growth hormone |
| 05/12/2004 | EP1171124A4 Anthelmintic compositions |
| 05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
| 05/12/2004 | EP1161410B1 Retinoid antagonists and use thereof |
| 05/12/2004 | EP1154778B1 Pharmaceutical preparation containing dithranol |
| 05/12/2004 | EP1154772B1 Agent for use in transplantation |
| 05/12/2004 | EP1152753B1 Combinations of formoterol and fluticasone propionate for asthma |
| 05/12/2004 | EP1146863B1 Lyophilisates with improved reconstitutibility |
| 05/12/2004 | EP1140835B1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 05/12/2004 | EP1131067B1 Composition and use of rar antagonists for promoting chondrogenesis |
| 05/12/2004 | EP1128738B1 A method for supplying bioavailable methionine to a cow |
| 05/12/2004 | EP1119254A4 Novel treatment for stroke management |
| 05/12/2004 | EP1114037B1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 05/12/2004 | EP1112070B1 Novel substituted triazole compounds |
| 05/12/2004 | EP1102745B1 A process for the preparation of zofenopril calcium salt |
| 05/12/2004 | EP1102592B1 Coumarin and related aromatic-based polymeric prodrugs |
| 05/12/2004 | EP1100497B1 Heterocyclyl sulphonamide derivatives |
| 05/12/2004 | EP1069898B1 Topical antiseptic compositions and methods |
| 05/12/2004 | EP1067966B1 Ophthalmic composition comprising a beta-blocker |
| 05/12/2004 | EP1066316B1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 05/12/2004 | EP1063235B1 Benzofurylpyrone derivatives |
| 05/12/2004 | EP1062212B1 Heterocyclyl anthracyclinone derivatives |
| 05/12/2004 | EP1058559B1 Combination of a selective nmda nr2b antagonist and a cox-2 inhibitor |
| 05/12/2004 | EP1054662B1 Water-soluble eye drop |
| 05/12/2004 | EP1052984B1 Antibacterial agents |
| 05/12/2004 | EP1036065B1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 05/12/2004 | EP1032264B1 Method of enhancing the antimicrobial properties of antibacterial antibiotics |
| 05/12/2004 | EP1028111B1 Amide derivatives or salts thereof |
| 05/12/2004 | EP1021179B1 Method of enhancing hair growth |
| 05/12/2004 | EP1020189B1 Nefiracetam for prevention and treatment of amnesia caused by propofol |
| 05/12/2004 | EP1015441B1 Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors |
| 05/12/2004 | EP1015429B1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa |
| 05/12/2004 | EP1007556B1 Troponin subunits and fragments useful as angiogenesis inhibitors |
| 05/12/2004 | EP0996418B1 Dermatological compositions |
| 05/12/2004 | EP0971731B1 Suppression of malignancy utilizing ribonucleotide reductase r1 |
| 05/12/2004 | EP0969720A4 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 05/12/2004 | EP0960105B1 Benzofurazan compounds that enhance ampa receptor activity |
| 05/12/2004 | EP0946510B1 Novel compounds with analgesic effect |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | EP0923371B1 Pharmaceutical compositions comprising tyrphostins |
| 05/12/2004 | EP0923369B1 1-o-alkylglycerols for pharmaceutical or veterinary use for preserving and/or improving sperm |
| 05/12/2004 | EP0917464B1 Use of amines to produce drugs for preventing tumour cell proliferation |
| 05/12/2004 | EP0912498B1 4(4-oxocyclohexyl) benzamides as intermediate products for medicaments |
| 05/12/2004 | EP0910415B1 Fluoro-labelled anthracycline and anthracyclinone derivatives |